Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality
17/09/2024 14:04
Sept 17 (Reuters) - PMD Device Solutions AB PMDDS.ST :
* STUDY DEMONSTRATED THAT 4 HOURS OF CONTINUOUS RESPIRATORY
RATE
MONITORING WITH RESPIRASENSE ACCURATELY PREDICTED 7-DAY
MORTALITY
Source text for Eikon: ID:nMFNPr81Y
Further company coverage: PMDDS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality